权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Elucidation of new molecular mechanism of cancer caused by gene promoter methylation and its clinical aplication

基因启动子甲基化致癌新分子机制阐明及其临床应用

基本信息

批准号：
14571198
负责人：
MATSUBARA Nagahide
金额：
$ 2.56万
依托单位：
OKAYAMA UNIVERSITY
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2002
资助国家：
日本
起止时间：
2002 至 2003
项目状态：
已结题

项目摘要

We have been studied molecular mechanisms of gastrointestinal carcinogenesis and cancer progression. One of our research focuses is colorectal cancer, and we have found the cancer specific mutation in E2F4, one of the important transcription factors, as a new gene strongly related to the colorectal cancer progression characterized as microsatellite instability phenotype (published 2 articles in Cancer Res.). We also found ING-1 as a new important target gene in esophageal squamouse cell cancer (published in Cancer Res.). We also studied the molecular events occur in early stages (just invaded into submucosa) of colorectal cancer, and we found high prevalence of microsatellite in low frequency (MSI-L) in this group of cancers (published in Cancer Res. ). Frequency of MSI-L in advanced colorectal cancer is really low around 10%, however, we found MSI-L phenotype in 50% of the early stage colorectal cancers. Now more and more researchers are involved in the new MSI-L carcinogenesis pathwa … More y, which was thought to be an artifact an thus not a meaningful phenomenon.Recently not only genetic, including mutations and deletions, but also epigenetic phenomenon are involved in many types of carcinogenesis. The most typical epigenetic alteration is the promoter hypermethylation, which causes the silencing of the gene. DNA methylation occurs preferentially within dense clusters of CpG sites know as CpG islands. Therefore reference is made to a CpG island methlator phenotype (CIMP). Most of our recent work was focused on this promoter methylation of multiple genes in gastrointestinal cancers, and we made tremendous progress in this field. We found that the important DNA repair gene MGMT (O6-methylguanine DNA methyltransferase) is controlled of its expression by promoter methylation, by analyzing precise map of methylation in its promoter. We also found that the level of methylation is strongly related to the prognosis and chemoresistance of colorectal cancers (Clinical Cancer Research). Furthermore, we classified colorectal cancer by mutational status of KRAS and BRAF, and showed close correlation to the methylation status of the multiple promoter methylation in colorectal cancer (Journal of Clinical Oncology). Less

我们已经研究了胃肠道癌发生和癌症进展的分子机制。我们的研究重点之一是结直肠癌，我们发现了重要转录因子之一E2 F4的癌症特异性突变，这是一个与结直肠癌进展密切相关的新基因，其特征是微卫星不稳定表型（在Cancer Res.上发表了2篇文章）。我们还发现ING-1是食管鳞癌中一个新的重要靶基因（发表在Cancer Res.）。我们还研究了发生在结直肠癌早期阶段（刚刚侵入粘膜下层）的分子事件，我们发现低频率微卫星（MSI-L）在这组癌症中的高患病率（发表在Cancer Res.）。MSI-L在晚期结直肠癌中的频率很低，约为10%，然而，我们在50%的早期结直肠癌中发现了MSI-L表型。目前，越来越多的研究者参与到MSI-L新的致癌途径中， ...更多信息近年来，许多类型的肿瘤发生不仅涉及遗传（包括突变和缺失），而且还涉及表观遗传现象。最典型的表观遗传学改变是启动子高甲基化，其导致基因沉默。DNA甲基化优先发生在称为CpG岛的CpG位点的密集簇内。因此，参考CpG岛甲基化子表型（CIMP）。我们最近的大部分工作都集中在胃肠道癌症中多个基因的启动子甲基化上，我们在这一领域取得了巨大的进展。通过对DNA修复基因MGMT（O 6-methylguanine DNA methyltransferase）启动子甲基化图谱的分析，发现其表达受启动子甲基化调控。我们还发现甲基化水平与结直肠癌的预后和化疗耐药性密切相关（临床癌症研究）。此外，我们通过KRAS和BRAF的突变状态对结直肠癌进行分类，并显示结直肠癌中多个启动子甲基化的甲基化状态密切相关（临床肿瘤学杂志）。少

项目成果

期刊论文数量（69）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers.

DOI：
发表时间：
2002-07
期刊：
Cancer research
影响因子：
11.2
作者：
Y. Mori;F. Sato;F. Selaru;Andreea Olaru;K. Perry;M. Kimos;G. Tamura;N. Matsubara;Suna Wang;Yan Xu;Jing Yin;T. Zou;B. Leggett;Joanne P Young;T. Nukiwa;O. Stine;J. Abraham;D. Shibata;S. Meltzer
通讯作者：
Y. Mori;F. Sato;F. Selaru;Andreea Olaru;K. Perry;M. Kimos;G. Tamura;N. Matsubara;Suna Wang;Yan Xu;Jing Yin;T. Zou;B. Leggett;Joanne P Young;T. Nukiwa;O. Stine;J. Abraham;D. Shibata;S. Meltzer

Allelic loss of a common microsatellite marker MYCL1:: A useful prognostic factor of poor outcomes in colorectal cancer

DOI：
10.1158/1078-0432.ccr-0779-3
发表时间：
2004-03-01
期刊：
CLINICAL CANCER RESEARCH
影响因子：
11.5
作者：
Kambara, T;Sharp, GB;Matsubara, N
通讯作者：
Matsubara, N

Takeshi Yamamoto, Takeshi Nagasaka, Kenji Notohara, Hiromi Sasamoto, Jun Murakami, Noriaki Tanaka, Nagahide Matsubara: "Methylation assay by nucleotide incorporation (MANIC) : a novel, nonisotopic, quantitative assay for regional CpG methylation density."

Takeshi Yamamoto、Takeshi Nagasaka、Kenji Notohara、Hiromi Sasamoto、Jun Murakami、Noriaki Tanaka、Nagahide Matsubara：“核苷酸掺入甲基化测定 (MANIC)：一种新颖的非同位素定量测定区域 CpG 甲基化密度。”